Catalog No.
KDA42301
Description
PRINCIPLE OF THE ASSAY This assay employs the quantitative sandwich enzyme immunoassay technique. Recombinant Human VEGFA has been pre-coated onto a microplate. Samples or standards are pipetted into microwells and Faricimab will be captured by immobilized Human VEGFA. After washing away any unbound substances, a biotin-labeled Human ANGPT2 is added to the wells. After washing away any unbound substances, Streptavidin-HRP is added to the wells. Following a wash to remove any unbound enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of Faricimab bound in the initial step. The color development is stopped and the intensity of the color is measured.
Applications
Used for the quantitative determination of Faricimab concentration in serum and plasma.
Detection method
Colorimetric
Sample type
Plasma, Serum
Assay type
Quantitative
Range
8.23 - 6,000 ng/mL
Sensitivity
4.51 ng/mL
Precision
Intra-Assay Precision (Precision within an assay): <10%
Three samples of known concentration were tested sixteen times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): <15%
Three samples of known concentration were tested in twenty four separate assays to assess inter-assay precision.
|
|
Intra-Assay Precision |
Inter-Assay Precision |
||||
|
Sample |
1 |
2 |
3 |
1 |
2 |
3 |
|
n |
16 |
16 |
16 |
24 |
24 |
24 |
|
Mean (ng/mL) |
1657.6 |
208.9 |
19.9 |
1667.7 |
195.3 |
20.8 |
|
Standard deviation |
124.7 |
12.4 |
1.5 |
192.6 |
17.1 |
3.0 |
|
CV (%) |
7.5 |
5.9 |
7.6 |
11.6 |
8.7 |
14.3 |
Recovery
80-120%
Shipping
2-8 ℃
Stability and Storage
When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%.
Alternative Names
RG7716, RO6867461, CAS: 1607793-29-2
Background
Faricimab: an investigational agent targeting the Tie-2/angiopoietin pathway and VEGF-A for the treatment of retinal diseases
For research use only. Not for human or drug use.
